We are very happy to announce that the call for Amsterdam UMC TKI-PPP grants is now open. The grant amounts available to both our UMCs will be combined, creating a pot of approximately 8-9 million euros that will be divided over the best TKI-research proposals that we will receive from all of you.
On September 30 a webinar was hosted by IXA to explain more in detail what the grant is about, what the requirements are and what the timeline and process entails. You can download the presentation of this webinar here or watch the webinar below.
For those of you who are unfamiliar with TKI grants and PPP-proposals, please click here to download the TKI-PPP flyer in which we explain all abbreviations, the details of the grant procedure, how proposals will be evaluated, and where the money comes from.
Those of you who have a proposal in mind and a private partner to collaborate with are invited to prepare and send in a pre-application using the form and budget sheet below no later than the deadline of November 20. In addition, a Letter of Intent from each private partner is required at this stage (see template below).
The Consortium Agreement (also below) comes in slightly different variants, depending on the number of industrial and/or academic partners. For now we have only attached a 1-on-1 version. Please provide your industrial partner(s) with this draft Consortium Agreement at an early stage, allowing your partner(s) to get acquainted with the conditions that they will need to accept once your joint application is awarded.
We look forward to receiving your proposals!
2. Budget form
Optics11 and Optics11 Life have secured funding from Rabobank. The funding will be used to strongly accelerate growth across global markets, to further build the team for the future and to strategically expand the high-tech product portfolios of both business units. “This is the right moment to pick up the pace. Rabobank’s funding helps us […]News
Is it possible to create a cup of coffee that’s healthy and tasty? At the entrepreneurship laboratory Demonstrator Lab at the Vrije Universiteit, Florian Fermin (27) and Stefan Wateler (26) developed Cuppelement, a Fairtrade biodegradable coffee capsule with added superfoods and vitamins. During the Dutch TV program Dragons Den, the entrepreneurs successfully persuaded the dragons […]News
Azafaros B.V. announced today that the first cohort of healthy subjects has been dosed in a two-part Phase 1 clinical study with clinical candidate AZ-3102, a first-in-class small molecule compound being developed for the treatment of rare neurogenetic disorders. This double-blind, placebo-controlled, Phase 1 study is evaluating the safety and tolerability of ascending single- (SAD) […]News